|  | | | | | | | | North Korea said 42 people had died as the country began its fourth day under a lockdown aimed at stopping its first confirmed COVID-19 outbreak. | | | | | | A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drugmaker failed to inform about known side effects. | | | | | | Two more cases of rare viral monkeypox infection have been diagnosed in England, health authorities said on Saturday, adding that they are not linked to one reported a week ago. | | | | | | North Korean leader Kim Jong Un said on Saturday the spread of COVID-19 had thrust his country into "great turmoil" and called for an all-out battle to overcome the outbreak, as 21 daily deaths were reported among people with fever. | | | | | | Britain will delay by a year new rules banning multi-buy deals on foods and drinks high in fat, salt, or sugar (HFSS), with the government saying on Saturday it needed more time given the cost of living crisis. | | | | | | Pfizer Inc and its German partner BioNTech SE said on Friday they had agreed to push back deliveries of their COVID-19 vaccines to the European Union by three months as the bloc prepares for a potential booster campaign in the fall. | | | | | | The U.S. Food & Drug Administration said on Friday it had approved Eli Lilly's injected drug tirzepatide, which has the brand name Mounjaro, to help improve blood sugar control in adults with type 2 diabetes. | | | | | | A team of Australian researchers have identified a biochemical marker in the blood that could help identify newborn babies at risk for sudden infant death syndrome (SIDS), a breakthrough they said creates an avenue to future tragedy-preventing interventions. | | | | | | The U.S. baby formula shortage should improve dramatically in coming weeks, President Joe Biden and top officials said on Friday as the administration scrambled to reverse a shortfall that hits lower-income Americans particularly hard. | | | | | | | | | | | | | | | Sponsors are not involved in the creation of these or any other Reuters news articles.
Get Reuters News App
To manage which newsletters you're subscribed to, click here.
Want to stop receiving this email? Unsubscribe here.
To contact us with feedback, reply to this email. | | | | | | | | | |
